{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:35:08Z","timestamp":1783496108468,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.semnephrol.2023.151474","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T03:34:06Z","timestamp":1706067246000},"page":"151474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Detection and Scoring of Extracorporeal Circuit Clotting During Hemodialysis"],"prefix":"10.1016","volume":"43","author":[{"given":"Floris","family":"Vanommeslaeghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van Biesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlien","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semnephrol.2023.151474_bib0001","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/sdi.12380","article-title":"Anticoagulation in chronic hemodialysis: Progress toward an optimal approach","volume":"28","author":"Kessler","year":"2015","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2023.151474_bib0002","article-title":"Unfractionated heparins, LMWH, direct thrombin inhibitors\u2014global perspectives of dosing regimens, guidelines and healthcare economics","author":"Santos","year":"2023","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151474_bib0003","article-title":"Immunologic effects of heparin associated with hemodialysis: Focus on heparin-induced thrombocytopenia","author":"Warkentin","year":"2024","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151474_bib0004","article-title":"Lipid and bone effects of heparin use during hemodialysis","author":"Stegmayr","year":"2024","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151474_bib0005","article-title":"Bleeding risk in hemodialysis patients","author":"Anita van Eck van der","year":"2024","journal-title":"Semin Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151474_bib0006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ckj\/sfac217","article-title":"Microemboli induced by air bubbles may be deposited in organs as a consequence of contamination during medical care","volume":"16","author":"Forsberg","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.semnephrol.2023.151474_bib57","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1111\/aor.12110","article-title":"Two-dimensional computational analysis of microbubbles in hemodialysis","volume":"37","author":"Keshavarzi","year":"2013","journal-title":"Artif Organs"},{"issue":"3-4","key":"10.1016\/j.semnephrol.2023.151474_bib0007","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000342596","article-title":"Bubble chamber clotting during continuous renal replacement therapy: Vertical versus horizontal blood flow entry","volume":"34","author":"Baldwin","year":"2012","journal-title":"Blood Purif"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151474_bib0008","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/aor.14495","article-title":"Venous chambers in clinical use for hemodialysis have limited capacity to eliminate microbubbles from entering the return bloodline: An in vitro study","volume":"47","author":"Jonsson","year":"2023","journal-title":"Artif Organs"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151474_bib0009","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1378\/chest.128.4.2918","article-title":"Microbubbles: Pathophysiology and clinical implications","volume":"128","author":"Barak","year":"2005","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151474_bib0010","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/hdi.12052","article-title":"A high blood level in the venous chamber and a wet-stored dialyzer help to reduce exposure for microemboli during hemodialysis","volume":"17","author":"Forsberg","year":"2013","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2023.151474_bib0011","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000451044","article-title":"Fundamental characteristics of the newly developed ATA membrane dialyzer","volume":"189","author":"Sunohara","year":"2017","journal-title":"Contrib Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151474_bib0012","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/ckj\/sfaa228","article-title":"Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: The SAFE study","volume":"14","author":"Vandenbosch","year":"2021","journal-title":"Clin Kidney J"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151474_bib0013","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.ekir.2019.07.010","article-title":"Evaluation of different dialyzers and the impact of predialysis albumin priming in intermittent hemodialysis with reduced anticoagulation","volume":"4","author":"Vanommeslaeghe","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151474_bib0014","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/ckj\/sfz163","article-title":"A randomized cross-over study with objective quantification of the performance of an asymmetric triacetate and a polysulfone dialysis membrane using different anticoagulation strategies","volume":"14","author":"Vanommeslaeghe","year":"2021","journal-title":"Clin Kidney J"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151474_bib0015","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/aor.13268","article-title":"Biocompatibility of polysulfone hemodialysis membranes and its mechanisms: Involvement of fibrinogen and its integrin receptors in activation of platelets and neutrophils","volume":"42","author":"Koga","year":"2018","journal-title":"Artif Organs"},{"key":"10.1016\/j.semnephrol.2023.151474_bib0016","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000450806","article-title":"A new poly(methyl methacrylate) membrane dialyzer, NF, with adsorptive and antithrombotic properties","volume":"189","author":"Oshihara","year":"2017","journal-title":"Contrib Nephrol"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2023.151474_bib0017","first-page":"1","article-title":"Polymethylmethacrylate membrane dialyzer: Historic but modern","volume":"52","author":"Torii","year":"2022","journal-title":"Blood Purif"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151474_bib0018","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/j.ajkd.2021.04.004","article-title":"Dialyzer performance during hemodialysis without systemic anticoagulation using a heparin-grafted dialyzer combined with a citrate-enriched dialysate: Results of the randomized crossover noninferiority EvoCit study","volume":"79","author":"Francois","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151474_bib0019","doi-asserted-by":"crossref","first-page":"e97187","DOI":"10.1371\/journal.pone.0097187","article-title":"Hemodialysis without systemic anticoagulation: A prospective randomized trial to evaluate 3 strategies in patients at risk of bleeding","volume":"9","author":"Guery","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151474_bib0020","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/ndt\/gfg272","article-title":"Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane","volume":"18","author":"Lavaud","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151474_bib0021","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/aor.13452","article-title":"Evaluation with micro-CT of different anticoagulation strategies during hemodialysis in patients with thrombocytopenia: A randomized crossover study","volume":"43","author":"Vanommeslaeghe","year":"2019","journal-title":"Artif Organs"},{"key":"10.1016\/j.semnephrol.2023.151474_bib0022","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2369-15-104","article-title":"Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: A retrospective cohort study","volume":"15","author":"Francois","year":"2014","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151474_bib0023","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/aor.13070","article-title":"Formation of blood foam in the air trap during hemodialysis due to insufficient automatic priming of dialyzers","volume":"42","author":"Jonsson","year":"2018","journal-title":"Artif Organs"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151474_bib0024","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bja.2019.09.012","article-title":"2019 EACTS\/EACTA\/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery","volume":"123","author":"Kunst","year":"2019","journal-title":"Br J Anaesth"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151474_bib0025","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1525-1594.1993.tb00408.x","article-title":"Heparin-free dialysis with an on-line hemodiafiltration system","volume":"17","author":"Wamsiedler","year":"1993","journal-title":"Artif Organs"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151474_bib0026","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/ckj\/sfaa219","article-title":"How biocompatible haemodialysers can conquer the need for systemic anticoagulation even in post-dilution haemodiafiltration: A cross-over study","volume":"14","author":"Vanommeslaeghe","year":"2021","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151474_bib0027","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2016.05.013","article-title":"Vitamin E-coated and heparin-coated dialyzer membranes for heparin-free hemodialysis: A multicenter, randomized, crossover trial","volume":"68","author":"Islam","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151474_bib0028","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1038\/s41598-018-20898-w","article-title":"Micro-computed tomography for the quantification of blocked fibers in hemodialyzers","volume":"8","author":"Vanommeslaeghe","year":"2018","journal-title":"Sci Rep"},{"issue":"4-5","key":"10.1016\/j.semnephrol.2023.151474_bib0029","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000072548","article-title":"Does monitoring of pre-\/post-dialyzer pressure difference improve efficiency in intermittent hemodialysis?","volume":"21","author":"Gabutti","year":"2003","journal-title":"Blood Purif"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151474_bib0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/sdi.12932","article-title":"Anticoagulation in hemodialysis: A narrative review","volume":"34","author":"Claudel","year":"2021","journal-title":"Semin Dial"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151474_bib0031","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1038\/s41598-022-09696-7","article-title":"Impact of intradialytic fiber clotting on dialyzer extraction and solute removal: A randomized cross-over study","volume":"12","author":"Vanommeslaeghe","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.semnephrol.2023.151474_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/TCRM.S150824","article-title":"Examining hemodialyzer membrane performance using proteomic technologies","volume":"14","author":"Bonomini","year":"2018","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151474_bib0033","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201700140","article-title":"Proteomic characterization of a new asymmetric cellulose triacetate membrane for hemodialysis","volume":"12","author":"Ronci","year":"2018","journal-title":"Proteomics Clin Appl"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151474_bib0034","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1525-139x.2000.00073.x","article-title":"Dialyzer reuse: What we know and what we don't know","volume":"13","author":"Kaplan","year":"2000","journal-title":"Semin Dial"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2023.151474_bib0035","first-page":"S2","article-title":"Clinical practice guidelines for hemodialysis adequacy, update 2006","volume":"48","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151474_bib0036","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/hdi.12113","article-title":"Effects of citrate-enriched bicarbonate based dialysate on anticoagulation and dialyzer reuse in maintenance hemodialysis patients","volume":"18","author":"Rocha","year":"2014","journal-title":"Hemodial Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151474_bib0037","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/hdi.12563","article-title":"Efficacy and safety of low-dose heparin in hemodialysis","volume":"22","author":"Murea","year":"2018","journal-title":"Hemodial Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151474_bib0038","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/ndt\/gfw461","article-title":"A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: Results of the CiTED study","volume":"32","author":"Meijers","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151474_bib0039","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/ajkd.2002.32788","article-title":"Dialyzer fiber bundle volume and kinetics of solute removal in continuous venovenous hemodialysis","volume":"39","author":"Liangos","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151474_bib0040","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ekir.2020.03.010","article-title":"Hemodialysis does not induce detectable activation of the contact system of coagulation","volume":"5","author":"Francois","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151474_bib0041","first-page":"177","article-title":"Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis","volume":"18","author":"Ballow","year":"2007","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151474_bib0042","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/ndt\/16.5.987","article-title":"Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets","volume":"16","author":"Sagedal","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151474_bib0043","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.thromres.2015.02.013","article-title":"The spectrum of thrombin in acute coronary syndromes","volume":"135","author":"Giri","year":"2015","journal-title":"Thromb Res"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151474_bib0044","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/iub.1333","article-title":"The hemostatic system as a regulator of inflammation in atherosclerosis","volume":"66","author":"Koch","year":"2014","journal-title":"IUBMB Life"},{"issue":"suppl 11","key":"10.1016\/j.semnephrol.2023.151474_bib0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ndt\/17.suppl_11.28","article-title":"The malnutrition, inflammation, and atherosclerosis (MIA) syndrome\u2014the heart of the matter","volume":"17","author":"Pecoits-Filho","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"20","key":"10.1016\/j.semnephrol.2023.151474_bib0046","first-page":"31530","volume":"S0085\u20132538","author":"Tran","year":"2020","journal-title":"A case-control study indicates that coagulation imbalance is associated with arteriosclerosis and markers of endothelial dysfunction in kidney failure, Kidney Int"},{"key":"10.1016\/j.semnephrol.2023.151474_bib0047","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ndt\/gfaa216","article-title":"Bleeding risk of haemodialysis and peritoneal dialysis patients","volume":"36","author":"van Eck van der Sluijs","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151474_bib0048","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10620-013-2973-6","article-title":"Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis","volume":"59","author":"Huang","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"36","key":"10.1016\/j.semnephrol.2023.151474_bib0049","doi-asserted-by":"crossref","first-page":"e1482","DOI":"10.1097\/MD.0000000000001482","article-title":"Different risk of common gastrointestinal disease between groups undergoing hemodialysis or peritoneal dialysis or with non-end stage renal disease: A nationwide population-based cohort study","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151474_bib0050","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2215\/CJN.08140814","article-title":"Comparison of subdural hematoma risk between hemodialysis and peritoneal dialysis patients with ESRD","volume":"10","author":"Wang","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151474_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143348","article-title":"Association of erythropoietin-stimulating agent responsiveness with mortality in hemodialysis and peritoneal dialysis patients","volume":"10","author":"Bae","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151474_bib0052","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000335685","article-title":"Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients","volume":"35","author":"Duong","year":"2012","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151474_bib0053","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0272-6386(87)80092-6","article-title":"Reducing the hemorrhagic complications of hemodialysis: A controlled comparison of low-dose heparin and citrate anticoagulation","volume":"9","author":"Flanigan","year":"1987","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151474_bib0054","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1093\/ndt\/gfq225","article-title":"Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding","volume":"25","author":"Kreuzer","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151474_bib0055","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1093\/ndt\/gfaa106","article-title":"Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults","volume":"35","author":"Gallieni","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"4 suppl 2","key":"10.1016\/j.semnephrol.2023.151474_bib0056","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"KDOQI Clinical Practice Guideline for Vascular Access: 2019 update","volume":"75","author":"Lok","year":"2020","journal-title":"Am J Kidney Dis"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T18:20:11Z","timestamp":1762280411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929523001845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0270929523001845"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151474","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection and Scoring of Extracorporeal Circuit Clotting During Hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151474"}}